11 Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991

12 Local antibody production and respiratory syncytial virus infection in children with leukaemia

13 Observations of clinical and chromosomal changes in a case of chronic granulocytic leukemia

14 A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490)

15 Nosocomial transmission of Saccharomyces cerevisiae in bone marrow transplant patients

16 Iron metabolism of established human hematopoietic cell lines in vitro

17 Apoptosis and content of mobile lipid domains in human leukemia K-562 cells induced to differentiate by quercetin or dimethyl sulfoxide.

18 Multifunctional Gold Nanoparticles Overcome MicroRNA Regulatory Network Mediated-Multidrug Resistant Leukemia

19 Automated shape-based clustering of 3D immunoglobulin protein structures in chronic lymphocytic leukemia

20 Targeting CD20 in chronic lymphocytic leukemia

21 Successful surgical management of invasive pulmonary fungal infection in patients with leukemia

22 Targeting CD20 in chronic lymphocytic leukemia

23 Successful surgical management of invasive pulmonary fungal infection in patients with leukemia

24 Targeting CD20 in chronic lymphocytic leukemia

25 Successful surgical management of invasive pulmonary fungal infection in patients with leukemia

26 Acute Myeloid Leukemia with Concomitant BCR-ABL and NPM1 Mutations

27 Composite Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and T-Prolymphocytic Leukemia Presenting with Lymphocytosis, Skin Lesions, and Generalized Lymphadenopathy

28 Report on Influenza A and B Viruses: Their Coinfection in a Saudi Leukemia Patient

29 The aberrant epigenetic regulation and epigenomic landscape alteration in human acute myelogenous leukemia and the emerged agents that target epigenetic regulators

30 [Precision medicine for acute myeloid leukemia based on genomic profiling].

31 A point mutation to the long terminal repeat of bovine leukemia virus related to viral productivity and transmissibility.

32 Childhood leukemia and traffic air pollution in Taiwan: petrol station density as an indicator.

33 Association of childhood leukemia with residential exposure to petrochemical air pollution in taiwan.

34 Caregiver Burden in the Patients of Acute Myeloblastic Leukemia.

35 New drugs approved for acute myeloid leukemia (AML) in 2018.

36 20-Cyclopropyl-cholecalciferol vitamin D<inf>3</inf>analogs: A unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines

37 Integrating expert opinion with clinical trial data to extrapolate long-term survival: a case study of CAR-T therapy for children and young adults with relapsed or refractory acute lymphoblastic leukemia.

38 Alantolactone selectively ablates acute myeloid leukemia stem and progenitor cells

39 Acute lymphoid and myeloid leukemia in a Brazilian Amazon population: Epidemiology and predictors of comorbidity and deaths.

40 Patient-Centered Insights on Treatment Decision Making and Living with Acute Myeloid Leukemia and Other Hematologic Cancers.

41 Are social inequalities in acute myeloid leukemia survival explained by differences in treatment utilization? Results from a French longitudinal observational study among older patients.

42 Health utility scores of family caregivers for leukemia patients measured by EQ-5D-3L: a cross-sectional survey in China

43 Ex vivo resistance in childhood acute lymphoblastic leukemia: Correlations between BCRP, MRP1, MRP4 and MRP5 ABC transporter expression and intracellular methotrexate polyglutamate accumulation.

44 Multidrug resistance genes in infant acute lymphoblastic leukemia: Ara-C is not a substrate for the breast cancer resistance protein.

45 The Outcomes of Chronic Myeloid Leukemia Patients With Molecular Warning Responses During Imatinib Treatment According to the European LeukemiaNet 2013 Recommendations.

46 Radotinib and its clinical potential in chronic-phase chronic myeloid leukemia patients: an update.

47 Outcomes of Chronic Myeloid Leukemia Patients With Early Molecular Response at 3 and 6 Months: A Comparative Analysis of Generic Imatinib and Glivec.

48 T Cell Leukemia/Lymphoma 1A is essential for mouse epidermal keratinocytes proliferation promoted by insulin-like growth factor 1.

49 Second malignant neoplasms in patients treated for childhood leukemia. A population-based cohort study from the Nordic countries. The Nordic Society of Pediatric Oncology and Hematology (NOPHO).

50 Migratory polyarthritis as a paraneoplastic syndrome in childhood leukemia.

51 A Quality Improvement Approach to Increase Exercise Assessment in Survivors of Childhood Leukemia.

52 Dexamethasone does not prevent malignant cell reintroduction in leukemia patients undergoing ovarian transplant: risk assessment of leukemic cell transmission by a xenograft model.

53 Successful treatment of disseminated fusariosis in a patient with acute lymphoblastic leukemia: A case report and literature review.

54 [Acute myeloid leukemia with sudden onset bilateral lower extremity paralysis caused by disseminated mucormycosis following unrelated bone marrow transplantation].

55 Prophylactic Measures During Induction for Acute Myeloid Leukemia.

56 Сase Report of Acute Toxic Imatinib-induced Hepatitis in a Patient with Chronic Myeloid Leukemia, Sulfa Allergy, and Rheumatoid Arthritis.

57 Vancomycin-resistance gene cluster, vanC, in the gut microbiome of acute leukemia patients undergoing intensive chemotherapy.

58 Procalcitonin and C-Reactive Protein As Markers of Bacteremia in Patients With Febrile Neutropenia Who Receive Chemotherapy for Acute Leukemia: A Prospective Study From Nepal.

59 Minimal Residual Disease in Chronic Lymphocytic Leukemia: A New Goal?

60 Paternal Smoking Before Conception and During Pregnancy Is Associated With an Increased Risk of Childhood Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis of 17 Case-Control Studies.

61 Antiproliferative and Immunoregulatory Effects of Azelaic Acid Against Acute Myeloid Leukemia the Activation of Notch Signaling Pathway.

62 In vitro activity of a G-quadruplex-stabilizing small molecule that synergizes with Navitoclax to induce cytotoxicity in acute myeloid leukemia cells.

63 Two Receptors, Two Isoforms, Two Cancers: Comprehensive Analysis of KIT and TrkA Expression in Neuroblastoma and Acute Myeloid Leukemia.

64 Benzene and leukemia: from scientific evidence to regulations. A historical example

65 The impact of concomitant cytogenetic abnormalities on acute myeloid leukemia with monosomy 7 or deletion 7q after HLA-matched allogeneic stem cell transplantation.

66 In vitro activity of resorcinarene–chlorambucil conjugates for therapy in human chronic myelogenous leukemia cells

67 The prevalence, risk factors, and prognostic value of anxiety and depression in refractory or relapsed acute myeloid leukemia patients of North China.

68 Extremely Low Frequency Electromagnetic Field (ELF-EMF) and childhood leukemia near transmission lines: a review

69 Idarubicin Dose Escalation During Consolidation Therapy for Adult Acute Myeloid Leukemia.

70 Assessment of response to imatinib therapy in patients with chronic myeloid leukemia with e13a2 and e14a2 transcripts of BCR/ABL1 gene.

71 Fatal Disseminated Infection by Trichosporon asahii Under Voriconazole Therapy in a Patient with Acute Myeloid Leukemia: A Review of Breakthrough Infections by Trichosporon spp.

72 Vitamin B6 Addiction in Acute Myeloid Leukemia.

73 Synergistic action of dual IGF1/R and MEK inhibition sensitizes childhood acute lymphoblastic leukemia (ALL) cells to cytotoxic agents and involves downregulation of STAT6 and PDAP1.

74 Phenotypic characterization of macrophages in the BMB sample of human acute leukemia.

75 Targeted removal of leukemia cells from the circulating system by whole-body magnetic hyperthermia in mice.

76 Publisher Correction: The long non-coding RNA HOXB-AS3 regulates ribosomal RNA transcription in NPM1-mutated acute myeloid leukemia (Nature Communications, (2019), 10, 1, (5351), 10.1038/s41467-019-13259-2)

77 [The impact of KIT and other concomitant gene mutations on the prognoses of patients with core-binding factor acute myeloid leukemia].

78 Evaluation of artesunate for the treatment of adult T-cell leukemia/lymphoma.

79 Hyperoxia Alters Ultrastructure and Induces Apoptosis in Leukemia Cell Lines.

80 Successful Treatment of Fanconi Anemia and T-Cell Acute Lymphoblastic Leukemia

81 Prevalence and molecular epidemiology of bovine leukemia virus in Colombian cattle

82 The up-to-date role of biologics for the treatment of chronic lymphocytic leukemia.

83 Synthesizing efficacious genistein in conjugation with superparamagnetic FeO decorated with bio-compatible carboxymethylated chitosan against acute leukemia lymphoma.

84 Acute leukemia in the time of COVID-19.

85 Identification and development of non-cytotoxic cell death modulators: Impact of sartans and derivatives on PPARγ activation and on growth of imatinib-resistant chronic myelogenous leukemia cells.

86 Blinatumomab for Acute Lymphoblastic Leukemia: The First Bispecific T-Cell Engager Antibody to Be Approved by the EMA for Minimal Residual Disease.

87 Chromatin accessibility promotes hematopoietic and leukemia stem cell activity

88 Paranasal Manifestations of Early Stage Chronic Lymphocytic Leukemia

89 MicroRNAs expression profiles as biomarkers and therapeutic tools in Turkish patients with chronic myeloid leukemia.

90 The role of B cells for in vivo T cell responses to a Friend virus-induced leukemia.

91 FBL-reactive CD8+ cytotoxic and CD4+ helper T lymphocytes recognize distinct Friend murine leukemia virus-encoded antigens.

92 Antigen-driven T cell clones can proliferate in vivo, eradicate disseminated leukemia, and provide specific immunologic memory.

93 Eradication of disseminated murine leukemia by treatment with high-dose interleukin 2.

94 Clinical importance of P-glycoprotein-related resistance in leukemia and myelodysplastic syndromes — first experience with their reversal

95 Molecularly targeted therapies in myelodysplastic syndromes and acute myeloid leukemias

96 Clinical classification of 109 chronic myeloid leukemia cases and its correlation with Ph chromosomes.

97 Listeria monocytogenes Meningitis Following Imatinib Mesylate-Induced Monocytopenia in a Patient with Chronic Myeloid Leukemia

98 Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in chronic lymphocytic leukemia

99 Acute tumor lysis syndrome induced by high-dose corticosteroids in a patient with chronic lymphatic leukemia

100 In vitro-induced resistance to the deoxycytidine analogues cytarabine (AraC) and 5-aza-2′-deoxycytidine (DAC) in a rat model for acute myeloid leukemia is mediated by mutations in the deoxycytidine kinase ( dck ) gene

101 Evidence for monoclonal proliferation in prolymphocytic leukemia of T- cell origin

Keyword Connections

Journals

Research Groups

Bibliographies